Utah Admin. Code 590-287-3

Current through Bulletin 2024-20, October 15, 2024

Section R590-287-3 - Definitions

Terms used in this rule are defined in Sections 31A-1-301 and 31A-48-102. Additional terms are defined as follows:

(1) "Drug product" means the finished dosage form of a drug that contains a drug substance, in association with other active or inactive ingredients, and that has a unique NDC.

(2) "FDA" means the United States Food and Drug Administration.

(3) "National Drug Code" or "NDC" means a three-segment code maintained by the FDA that is converted to an 11-digit format and includes a:

(a) labeler code;

(b) product code; and

(c) package code.

(4) "WAC" means wholesale acquisition cost.

Utah Admin. Code R590-287-3

Adopted by Utah State Bulletin Number 2022-11, effective 5/11/2022